# LEXEO THERAPEUTICS INC (LXEO)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/LXEO/

- Reporting holders: 2
- Reported value: $3.9K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $2.7K | 812 | 0.0% | 2 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $1.1K | 340 | 0.0% | 4 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 2 | $3.9K |
| Q2 2026 | 146 | $456.6M |
| Q1 2026 | 139 | $459.3M |
| Q4 2025 | 145 | $759.5M |
| Q3 2025 | 110 | $327.7M |
| Q2 2025 | 92 | $169.9M |
| Q1 2025 | 89 | $100.2M |
| Q4 2024 | 89 | $194.2M |
| Q3 2024 | 67 | $269.7M |
| Q2 2024 | 58 | $426.3M |
| Q1 2024 | 54 | $362.1M |
| Q4 2023 | 31 | $217.2M |